ISHLT: The International Society for Heart & Lung Transplantation

Boards & Committees - Annual Meeting

2014 ANNUAL MEETING PROGRAM COMMITTEE
COMMITTEE LEADERSHIP	ABOUT THE COMMITTEE
EXECUTIVE TEAM	COMMITTEE CATEGORIES The Symposia Planning Committee members have been selected to represent the following categories: • BASIC AND TRANSLATIONAL SCIENCE • HEART • INFECTIOUS DISEASES • LUNG • MCS • NURSING ALLIED HEALTH • PATHOLOGY • PEDIATRICS • PHARMACY/PHARMACOLOGY • PULMONARY HYPERTENSION QUICK LINKS/INFO Meeting Webpage Symposia Planning Meeting: July 20-21, 2013, Philadelphia, PA, USA Abstract Selection Meeting and Conference Calls: December 16-17, 2013, Washington, DC COMMITTEE COMPOSITION The Annual Meeting Scientific Program Committee shall consist of a Vice-Chair appointed by the President-Elect and a Chair who shall rotate into the position after serving as Vice-Chair. Chair and Vice-Chair terms are one year each. The Chair shall appoint sufficient additional committee members to reflect the disciplines of the abstract categories and to ensure, to the extent possible, representation from among the various geographic and specialty constituencies of the Society. Such terms are for one year. The Immediate Past Chair, the Editor of the Journal, the President, and the Chair of the Development Committee shall also serve as members of the Program Committee. If not already an elected Board member, the Chair of the Annual Meeting Scientific Program Committee shall serve as an ex-officio member of the Board of Directors and shall also serve as a member of the Education Committee. COMMITTEE RESPONSIBILITIES Develop learning objectives for the Annual Meeting that are tied to the identified educational needs of the members. Ensure that the Annual Meeting Scientific Program meets the identified educational needs of the members and the established learning objectives. Develop the Annual Meeting Scientific Program content, including the selection of abstract presentations and the development and selection of symposia. Make revisions to the scientific program to ensure it continues to meet the educational needs of the members. Evaluate and make changes, as needed, to the format, structure, and content development process of the Annual Meeting Scientific Program
PROGRAM CHAIR Jason D. Christie, MD, MS University of Pennsylvania Philadelphia, Pennsylvania, USA 215-573-3209 jchristi@mail.med.upenn.edu Jason Christie, MD, MS, is the Section Chief of Medical Critical Care at the University of Pennsylvania Perelman School of Medicine. He is currently Associate Professor of Epidemiology in the Department of Biostatistics and Epidemiology at the University of Pennsylvania. He is a Senior Scholar in the Center for Clinical Epidemiology and Biostatistics, and the Director of Clinical Research in the Pulmonary Division. His career is focused on translational research studies of the risks, pathogenesis, treatment, and outcomes of acute lung injury (ALI) in the transplant and non-transplant human populations.. PRESIDENT and PAST PROGRAM CHAIR Allan R. Glanville, MD, FRACP St. Vincent's Hospital Sydney, AUSTRALIA 61-2-8382-3257 aglanville@stvincents.com.au Professor Glanville trained in Sydney, Brompton Hospital, London and Stanford University, California. Currently working as a specialist in Lung Transplantation at St. Vincent's Hospital Sydney, he is actively involved with international trials into new immunosuppressive and anti-viral agents. He is Global Principal Investigator for the European and Australian Investigators in Lung Transplantation CeMyLungs trial, and sits on the Editorial Board of the American Journal of Respiratory and Critical Care Medicine. He has authored over 140 publications including approaches to antibody mediated rejection, bronchoscopic surveillance, RSV, CMV, Chlamydia and mycobacteria. He is the senior author of the International Guidelines for Lung Transplantation, foundation director of Outcomes Australia and a foundation member of ShareLife Australia. PROGRAM CHAIR-ELECT Andreas Zuckermann, MD, Medical University of Vienna Vienna, AUSTRIA 43-1-40400-5643 andreas.zuckermann@meduniwien.ac.at Bio coming soon...
COMMITTEE MEMBERS (in alphabetical order by CATEGORY)
BASIC SCIENCE
John A. Belperio, MD UCLA Pulmonary & Critical Care Medicine Los Angeles, California, USA 310-794-1999 jbelperio@mednet.ucla.edu Bio coming soon... Esmé Dijke, PhD University of Alberta Edmonton, Alberta, CANADA 780-492-7259 esmedijke@med.alberta.ca Esmé Dijke works as a Post-doctoral Fellow at the University of Alberta in Edmonton under the supervision of Dr. Lori West. She graduated cum laude from the Rotterdam University in Rotterdam (Netherlands) with a Bachelor of Applied Sciences degree in Biotechnology. She received her PhD in the laboratory of Dr. Carla Baan and Dr. Willem Weimar at the Erasmus University in Rotterdam, where her doctoral studies focused on the role of regulatory T cells in adult heart transplant recipients. Her research interests are the role of regulatory T cells and B-cell memory in infants and its possible relation to development of tolerance to graft antigens. Daniel C. Chambers, MBBS, MD The Prince Charles Hospital Brisbane, Queensland, AUSTRALIA 61-7-31394000 Daniel_Chambers@health.qld.gov.au Dan Chambers, MBBS MRCP FRACP MD, is a Thoracic and Transplant Physician and Head of Research in the Queensland Lung Transplant Service, Prince Charles Hospital, Brisbane, Australia. He is also Associate Professor in the School of Medicine, University of Queensland, and Deputy Chair of the Metropolitan North Human Research and Ethics Committee. He is a member of the Lung Standing Committee for the Transplantation Society of Australia and New Zealand, and the Research Subcommittee for the Thoracic Society of Australia and New Zealand. His main research interests include the pathogenesis of chronic lung allograft dysfunction, early detection of lymphocytic bronchiolitis, lung metagenomics, adult lung disease complicating extreme preterm birth and cell therapy for advanced lung disease. Lori J. West, MD, DPhil University of Alberta Edmonton, Alberta, CANADA 780-492-3200 ljwest@ualberta.ca Dr. Lori West is the Director of Heart Transplantation Research and a Professor of Pediatrics, Surgery and Immunology at the University of Alberta - one of the largest heart transplant programs in the world. Dr. West completed her pediatric residency at Harbor-UCLA Medical Center. She trained in pediatric cardiology at the Hospital for Sick Children, Toronto, and subsequently in pediatric transplant cardiology at Pittsburgh Children's Hospital, Loma Linda University Medical Center and Columbia-Presbyterian Children's Hospital. She obtained her PhD for specialized training in transplant immunology research at Oxford University and works in the role of a clinician-scientist.
HEART
Marisa Crespo-Leiro, MD Hospital Universitario A Coruña La Coruña, SPAIN 34-981-178-304 Marisa.Crespo.Leiro@sergas.es Maria G (Marisa) Crespo-Leiro, MD, PhD, FESC, is the Medical Director of the Advanced Heart Failure Transplant Unit at the Hospital Universitario A Coruña, La Coruña, Spain. She obtained her MD degree at the University of Santiago de Compostela, her specialization in cardiology at Clinica Puerta de Hierro in Madrid and her PhD from Universidad Autónoma de Madrid. Since 1993 she has been working in the Heart Division at the Hospital Universitario A Coruña (formerly the Hospital Universitario Juan Canalejo) in La Coruña, where she is also Associate Professor of Medicine. Her main fields of research interest are heart failure and heart transplantation. Göran Dellgren, MD Sahlgrenska University Hospital Goteborg, SWEDEN 46-31-342-88-63 goran.dellgren@vgregion.se Bio coming soon... Howard J. Eisen, MD, FAHA, FACC, FACP Drexel University College of Medicine and Hahnemann University Hospital Philadelphia, PA, USA 215-762-5080 Howard.Eisen@DrexelMed.edu Dr. Eisen obtained his MD from the University of Pennsylvania (UPenn) School of Medicine in 1981 where he was elected to Alpha Omega Alpha. He completed his internal medicine residency at the Hospital of UPenn (1981-1984), followed by a fellowship in cardiovascular medicine at Washington Univ in St. Louis and Barnes Hospital (1984-87) where he received training in the management of cardiac transplant recipients. He subsequently was on the faculty of UPenn School of Medicine and Temple Univ before joining the Drexel Univ College of Medicine and Hahnemann Univ Hospital as Chief of the Division of Cardiology in 2005. Dr. Eisen has been funded by the NIH to study microchimerism and cell adhesion molecule expression in cardiac transplant rejection and has played an important role in the investigation of gene expression profiling in cardiac transplantation. Dr. Eisen is board certified in Internal Medicine, Cardiovascular Diseases and Advanced Heart Failure and Transplant Cardiology by the American Board of Internal Medicine. David S. Feldman, MD, PhD Minneapolis Heart Institute Minneapolis, Minnesota, USA 612-863-3900 dfeldman@mplsheart.com Bio coming soon... Ashish S. Shah, MD Johns Hopkins Hospital Baltimore, Maryland, USA 410-502-3900 ashah29@csurg.jhmi.jhu.edu Bio coming soon... Michal Zakliczynski, MD Slaskie Centrum Chorb Serca Zabrze, POLAND 48-516-073-146 zaklimed@onet.pl Bio coming soon...
INFECTIOUS DISEASES
Stanley I. Martin, MD Ohio State University Medical Center Columbus, Ohio, USA 614-293-5666 stanley.martin@osumc.edu Stanley Martin, MD, is an Assistant Professor in the Division of Internal Medicine at The Ohio State University Medical Center. Dr. Martin has a clinical and research interest in infectious diseases related to non-HIV immunocompromised hosts. His work and training have focused mainly on patients undergoing solid organ and bone marrow transplantation. His research interests have included molecular virology in transplantation, xenotransplantation, and infectious complications of monoclonal antibody therapy. Dr. Martin earned his MD at the University of Tennessee and subsequently completed his internship and residency in Internal Medicine at the Mayo Clinic in Rochester, MN. He went on to complete an infectious diseases fellowship at Massachusetts General Hospital in Boston, MA. Amparo Sole, MD, PhD University Hospital la Fe Valencia Valencia, SPAIN 34-61-656-6203 sole_amp@gva.es Amparo Sole, MD, PhD, is a pulmonologist professor of lung transplant medicine at EVESP (Escuela valenciana de estudios superiores). She is Director of the Adult Cystic Fibrosis Unit and Senior Consultant of the Lung Transplant Unit at the University and Polytechnic Hospital La Fe in Valencia, Spain. Her clinical interests include lung transplant, heart-lung transplant, transplant outcomes, and cystic fibrosis. She has developed her career in the field of lung transplant at several hospitals around the world, being a visitor and researcher at the Royal Brompton Hospital of London, Freeman Hospital in Newcastle (England), Toronto General Hospital in Ontario (Canada), and at St. Vincent's Hospital in Sydney (Australia). She was president of the 33rd European Cystic Fibrosis Conference held in Valencia in June, 2010. Currently she is the President of the Spanish Scientific Society of Cystic Fibrosis.
LUNG
Tobias Deuse, MD, PhD University Heart Center Hamburg Hamburg, GERMANY 49-152-2281-6664 t.deuse@uke.de Bio coming soon... Allan R. Glanville, MD, FRACP St. Vincent's Hospital Sydney, AUSTRALIA 61-2-8382-3257 aglanville@stvincents.com.au See bio above under "President and Past Program Chair" Denis Hadjiliadis, MD University of Pennsylvania Philadelphia, Pennsylvania, USA 215-615-3871 hadjiliadisdenis@hotmail.com Dr Hadjiliadis is the Paul F Harron Jr Associate Professor of Medicine and the Director of the Adult Cystic Fibrosis Program at the University of Pennsylvania and a member of the Lung Transplant Program at the University of Pennsylvania. He is also the physician leader of the Advanced Lung Disease Research Group. Dr Hadjiliadis completed his medical degree at the University of Toronto, his Internal Medicine residency at the Mayo Clinic and his Pulmonary and Critical Care fellowship at Duke University Medical Center. He subsequently completed an advanced fellowship in Lung Transplantation and Cystic Fibrosis at the University of Toronto and joined its faculty prior to coming to the University of Pennsylvania. His main interests include patient selection and outcomes in lung transplantation, clinical trials in cystic fibrosis and prediction of outcomes and complications in cystic fibrosis. He is board certified by ABIM in Internal Medicine, Pulmonary Disease and Critical Care and by the Royal College of Physicians and Surgeons of Canada in Internal medicine and Respirology. David Lederer, MD, MS Columbia University Medical Center New York, NY, USA dl427@columbia.edu Bio coming soon... Christopher H. Wigfield, MD FRCS(C/Th) The University of Chicago Medicine & Biological Sciences Chicago, Illinois, USA 773-702-3554 cwigfield@surgery.bsd.uchicago.edu Christopher Wigfield, MD, MD, FRCS(C/Th), is Assistant Professor of Cardiothoracic Surgery at The University of Chicago. Dr. Wigfield received his clinical MD at Freie Universitaet Berlin, Germany and an additional Medical Sciences MD from the University of Newcastle upon Tyne, United Kingdom. He completed residencies in General Surgery at Royal Berkshire Hospital and at Freeman Hospital in the UK and went on to complete a fellowship in Cardiothoracic Surgery and Cardiopulmonary Transplantation at the Cardiothoracic Centre in Newcastle upon Tyne, UK. He also completed a Cardiothoracic Surgery fellowship at the University of Wisconsin Hospitals and Clinics in Madison, Wisconsin, USA. Dr. Wigfield's clinical and research interests are in thoracic surgery, lung transplantation, robotic assisted surgery and minimally invasive thoracic surgery. He has a dedicated educational portfolio. Martin R. Zamora, MD Colorado University Health Science Center Aurora, Colorado, USA 720-848-2259 marty.zamora@ucdenver.edu Bio coming soon...
MECHANICAL CIRCULATORY SUPPORT
Emma J. Birks, MBBS, PhD, BSc, FRCP University of Louisville Louisville, Kentucky, USA 502-561-2180 e.birks@imperial.ac.uk Emma Birks, MBBS, PhD, FRCP, is the Medical Director of the Jewish Hospital Heart Failure, Transplantation and Mechanical Circulatory Support program and Professor of Cardiovascular Medicine with the University of Louisville. Dr. Birks received her medical training, including her residency and fellowship, at the Royal Free Hospital School of Medicine / University of London. Jennifer Ann Cowger, MD, MS St. Vincent's Hospital Indianapolis, Indiana, USA jennifercowger@gmail.com Jennifer Cowger, MD, MS, is a clinical lecturer in Cardiovascular Medicine. Her expertise is in advanced heart failure, cardiac transplant, and mechanical support of the heart. Dr. Cowger received her medical degree from the Ohio State University, graduating class valedictorian in 2001. She completed her Internal Medicine Residency at Duke University Medical Center in Durham, North Carolina in 2004. She received her Cardiovascular Medicine Fellowship training at the University of Michigan with subspecialty training in Heart Failure and Cardiac Transplant which was completed in 2007. After concluding her medical education, Dr. Cowger obtained a Masters in Clinical Research and Statistics at the University's School of Public Health. Dr. Cowger's research interests are in mechanical circulatory support of the heart using left ventricular assist devices (LVADs). Her specific research area of focus is on imporving patient outcomes with long term LVAD support. She is also interested in investigating novel means of reducing oxidative stress in the setting of heart failure. Josef Stehlik, MD, PhD University of Utah Salt Lake City, UT, USA 801-585-2340 josef.stehlik@hsc.utah.edu Josef Stehlik, MD, MPH is an Associate Professor of Medicine at the University of Utah School of Medicine. Dr. Stehlik received his medical degree from Charles University in Prague and Masters in Public Health degree from Harvard School of Public Health. He completed his training in Internal Medicine and in Cardiovascular Diseases at Allegheny General Hospital, MCPHahnemann University and advanced training in Heart Failure and Transplantation at the Cleveland Clinic. Dr. Stehlik has been on faculty at the University of Utah since 2004 and serves as Medical Director of the Heart Transplant Program at the University of Utah Hospital and the Salt Lake City Veterans Affairs Medical Center. He has been active in clinical work, education and research in the areas of advanced heart failure, heart transplantation and mechanical circulatory support. Martin Strueber, MD University Heart Center Leipzig Leipzig, GERMANY 49-341865 1319 / 1421 martin.strueber@med.uni-leipzig.de Bio coming soon...* Marian Zembala, MD, PhD Silesian University Center Heart Disease Tarnowskie Góry, POLAND 48-32-33-285-4208 m.zembala@sccs.pl Bio coming soon... Andreas Zuckermann, MD, Medical University of Vienna Vienna, AUSTRIA 43-1-40400-5643 andreas.zuckermann@meduniwien.ac.at Bio coming soon...
NURSING ALLIED HEALTH
Samantha J. Anthony, PhD, MSW Hospital for Sick Children Toronto, Ontario, CANADA 416-813-7006 samantha.anthony@sickkids.ca Bio coming soon... Kevin Carney, RN, CCTC Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, USA 215-200-0260 Kevin.Carney@uphs.upenn.edu Bio coming soon...
PATHOLOGY
Gerald J. Berry, MD Stanford University Stanford, California, USA 650-723-7211 gjberry@stanford.edu Bio coming soon...
PEDIATRICS
Christian Benden, MD University Hospital Zurich Zurich, Switzerland christian_benden@yahoo.de Dr. Christian Benden is the Medical Director of Lung Transplantation at the University Hospital Zurich and a Reader in Pulmonology and Transplant Medicine at the University of Zurich, Switzerland. Dr. Benden completed his pediatric training in Hannover (Germany) and London (United Kingdom). In addition, he trained in Pediatric Pulmonology and received specialist training in lung transplantation in London and Zurich. Dr. Benden is a well-recognized Pediatric Lung Transplant Physician, and a former Chair of the ISHLT Scientific Council on Pediatric Transplantation. His research interests include clinical aspects of lung transplantation, particularly in children and adolescents, experimental aspects of chronic lung allograft dysfunction, and cystic fibrosis lung disease. Tajinder P. Singh, MD Children's Hospital of Boston Boston, Massachusetts, USA 617-355-0558 tp.singh@cardio.chboston.org Dr. Singh joined Boston Children’s Hospital’s Cardiovascular and Heart Transplant Program in 2005. He was previously medical director of the Heart Transplant Program at Children's Hospital of Michigan from 1998-2005. He is a clinical researcher with interest in (1) outcomes in children with heart failure and transplant, and (2) cardiovascular physiology (exercise physiology, cardiac innervation, vascular physiology, myocardial metabolism) in children with congenital and acquired heart disease. He has published several studies describing risk factors of mortality in children while waiting and after transplant. Dr. Singh holds an academic appointment as Assistant Professor at Harvard Medical School.
PHARMACY / PHARMACOLOGY
Tamara E. Claridge, PharmD Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, USA 215-615-8023 tamara.claridge@uphs.upenn.edu Bio coming soon... Walter Uber, PharmD Medical University of South Carolina Charleston, South Carolina, USA 843-876-4977 uberwe@musc.edu Bio coming soon...
PULMONARY HYPERTENSION
Prof Paul A. Corris Freeman Hospital Newcastle University & CT Centre Newcastle Upon Tyne, UNITED KINGDOM 44-191-223-1084 paul.corris@ncl.ac.uk Bio coming soon... Marc de Perrot, MD, MSc Toronto General Hospital Toronto, Ontario, CANADA 416-340-5549 Marc.DePerrot@uhn.ca Bio coming soon.... Mandeep R. Mehra, MD, MBBS, FACC, FACP Brigham & Women's Hospital Boston, MA, USA 617-732-8535 mmehra@partners.org Dr. Mehra, an internationally recognized cardiologist with expertise in the treatment of heart failure and heart muscle damage, cardiac transplantation and mechanical circulatory devices, is professor of Medicine at Harvard Medical School and Executive Director of the Center for Advanced Heart Disease at the Brigham and Women's Hospital in Boston, MA (USA). He obtained his cardiovascular training at the Ochsner Clinic Foundation, where he sub-specialized in the field of advanced heart failure and cardiac transplantation. He is board certified in internal medicine and cardiovascular diseases. His specific research interests in cardiac transplantation focus on post-transplant coronary arterial disease, new immunosuppressive therapy to improve heart transplant outcomes, and bringing genomic and proteomic science (the study of protein interactions in the body) to the bedside. In the field of heart failure, his research has focused on the role of new devices and novel serum markers to guide diagnosis and therapy. Myung H. Park, MD University of Maryland School of Medicine Baltimore, MD, USA 410-328-7260 mpark@medicine.umaryland.edu Myung Park, MD, FACC, is Director of the Pulmonary Vascular Diseases Program & CCU, and Associate Professor of Medicine, at the University of Maryland Medical Center. After receiving her medical degree from the Temple University School of Medicine, Dr. Park continued her training in Philadelphia with an internship and residency in internal medicine at Temple University Hospital.This was followed by a fellowship in cardiovascular medicine at the Medical College of Virginia. She furthered her training by completing an advanced fellowship in Heart Failure and Cardiac Transplantation at the Cleveland Clinic Foundation. Dr. Park is board certified in cardiology and internal medicine. She specializes in pulmonary hypertension, heart transplantation, advanced heart failure, and ventricular assist devices. Fernando Torres, MD UT Southwestern Medical Center Dallas, Texas, USA 214-645-5989 fernando.torres@utsouthwestern.edu Bio coming soon...